Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-16.29	175.14	-209.21
Graham Fair Price	-78.95	0.50	2.38
PEG	2320.31	-7.32	0.30
Price/Book	-13.97	1.31	1.52
Price/Cash Flow	-124.26	-18.07	-8.06
Prices/Earnings	1851.21	745.36	-38.20
Price/Sales	-46.28	8.70	16.20
Price/FCF	-124.26	-18.07	-8.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	24.69	0.33	0.27
Operating Margin	-83.75	0.02	-0.13
ROA	-95.26	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-95.59
ROIC	< 0.005	< 0.005	-60.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.20	0.06	247.91
Dividends QOQ	-0.35	0.07	-78.69
EBIT QOQ	-1.29	1.16	-10.19
EPS QOQ	-1.26	1.02	-19.38
FCF QOQ	-2.00	0.13	-93.33
Revenue QOQ	-0.74	0.40	-45.56
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	164.50	124.06	-24.58
Days Sales Outstanding (DSO)	797.16	443.85	-44.32
Inventory Turnover	0.55	0.73	32.60
Debt/Capitalization	0.42	0.35	-16.16
Quick Ratio	1.02	1.13	11.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	5.03	5.58	10.96
Cash	1.14	1.64	43.03
Capex	-0.35	0.16	-53.13
Free Cash Flow	-0.95	-0.36	61.54
Revenue	0.47	0.76	60.56
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	1.26	1.27	0.80
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-52.21	21.39	-59.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating